Tango Therapeutics (TNGX) Capital Expenditures (2020 - 2026)
Tango Therapeutics (TNGX) recorded quarterly Capital Expenditures of -$2000.0 in Q1 2026, down 100.9% quarter-over-quarter from $222000.0 in Q4 2025, and down 103.92% on a YoY basis from $51000.0 in Q1 2025.
Tango Therapeutics (TNGX) Capital Expenditures (2020 - 2026) Analysis & Trends
Tango Therapeutics' Capital Expenditures history runs 7 years deep, the most recent figure standing at -$2000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 103.92% year-over-year to -$2000.0; the TTM figure through Mar 2026 stood at $995000.0 (up 63.11% YoY), while the FY2025 annual figure was $1.0 million, up 38.99% from the prior year.
- Capital Expenditures was -$2000.0 for Q1 2026 at Tango Therapeutics, down from $222000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $5.8 million in Q3 2022 to a low of -$512000.0 in Q3 2024.
- Historically, Capital Expenditures has averaged $648117.6 across 5 years, with a median of $290000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 11556.0% in 2022, then sank 3300.0% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $1.0 million in 2022, then tumbled by 78.29% to $226000.0 in 2023, then jumped by 232.3% to $751000.0 in 2024, then tumbled by 70.44% to $222000.0 in 2025, then plunged by 100.9% to -$2000.0 in 2026.
- The last three Capital Expenditures figures came in at -$2000.0 (Q1 2026), $222000.0 (Q4 2025), and $570000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Tango Therapeutics | 4.05 Bn | 3.67 Bn | - | -2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,000.00 |
| Mar 31, 2026 | -2,000.00 |
| Dec 31, 2025 | 222,000.00 |
| Dec 31, 2025 | 222,000.00 |
| Sep 30, 2025 | 570,000.00 |
| Sep 30, 2025 | 570,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 751,000.00 |
| Dec 31, 2024 | 751,000.00 |
| Sep 30, 2024 | -512,000.00 |
| Sep 30, 2024 | -512,000.00 |
| Jun 30, 2024 | 320,000.00 |
| Jun 30, 2024 | 320,000.00 |
| Mar 31, 2024 | 195,000.00 |
| Mar 31, 2024 | 195,000.00 |
| Dec 31, 2023 | 226,000.00 |
| Dec 31, 2023 | 226,000.00 |